Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia
Public ClinicalTrials.gov record NCT00656994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Safety Study to Evaluate the Long-term Effects of TAK-375 on Endocrine Function in Adult Subjects With Chronic Insomnia
Study identification
- NCT ID
- NCT00656994
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- Ramelteon Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2002
- Primary completion
- Jun 30, 2004
- Completion
- Jun 30, 2004
- Last update posted
- Feb 27, 2012
2003 – 2004
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Jasper | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | La Palma | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Austell | Georgia | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Des Moines | Iowa | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Prairie Village | Kansas | — | — |
| Not listed | Florence | Kentucky | — | — |
| Not listed | Wentzville | Missouri | — | — |
| Not listed | Kenilworth | New Jersey | — | — |
| Not listed | South Plainfield | New Jersey | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Ninety Six | South Carolina | — | — |
| Not listed | Sioux Falls | South Dakota | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | San Angelo | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00656994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00656994 live on ClinicalTrials.gov.